All News

The second Remicade biosimilar is only the fifth biosimilar approved in the United States.

Anthem is parting ways with Express Scripts.

NACDS’s Gourlay embraces leading the industry proactively through changing health-care industry.

Expanded scope-of-practice/health-and-wellness figure prominently in new strategy.

DIR fees top pharmacy legislator meetings.

Recommended number of HPV injections for kids under 14 drops to two.

Making nonmedical vaccination exemptions more difficult to obtain can reduce risk of a measles epidemic.

Pharmacists and pharmacy groups are taking part in a national march in support for science.

The HHS is giving out greatly needed funds, but money alone may not be enough.

Tobacco is gone, now CVS launches new campaign aimed at promoting health and beauty.

Nearly 20 health-care organizations and PBMs come out in favor of FAST Generics Act.

Drug spending is going down at CVS Caremark. Here’s why.

Pharmacy chain will introduce testing and treatment for sexually transmitted infections at its clinics.

Schools of pharmacy are offering fellowships, certificates, and other training for a value-based health-care system.

Compounding pharmacist's case hinged on whether he was "willfully indifferent."

The problems your patients have-what you can do about it.

Naloxone is available, but is it actually being used?

Pharmacists are now recognized as providers nearly everywhere-now that they have the status, what does it mean?

What do you do about the customer who is never satisfied?

Is Trump focusing on the wrong thing?

The length of an initial opioid prescription influences the risks of long-term use.

How pharmacists can help fight the battle.

The New Drug Review for April

Cardiac Matters-What you need to know about anakinra

Special pill bottle caps can help reduce medication misuse and abuse.

How Trinity Health and Pacira are minimizing opioid use.

The citizens petition process is being used to delay approval of generic drugs.